A method for preventing and inhibiting human hla alloimmune response to platelet transfusion
CA 2325619 A1 · Owner: Freedman, John · Inventors: Lazarus, Alan H.; Freedman, John; Crow, Andrew R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a method for preventing HLA alloimmune response to platelet transfusion. The method comprises the step of presensitizing platelets with at least one monoclonal HLA antibody. The platelets if administered to a patient prevent an HLA alloimmune response from said patient.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 10, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 10, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 10, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.